Skip to main content
Roberto Civitelli, MD, Endocrinology, Saint Louis, MO

RobertoCivitelliMD

Endocrinology Saint Louis, MO

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid

Sydney M. & Stella H. Schoenberg Professor of Medicine; Professor of Orthopaedic Surgery and Cell Biology and Physiology; Chief, Division of Bone and Mineral Diseases; Musculoskeletal Research Center; Washington University School of Medicine

Dr. Civitelli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Civitelli's full profile

Already have an account?

  • Office

    10 Barnes West Dr
    Ste 200
    Saint Louis, MO 63141
    Phone+1 314-454-7775
    Fax+1 314-996-3087

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1988
  • Univ Siena- Fac Med
    Univ Siena- Fac MedClass of 1980

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1989 - 2025

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians, 2005
  • Fuller Albright Award American Society for Bone and Mineral Research, 1995
  • Kappa Delta Award American Academy of Orthopaedic Surgeons, 1994
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Focusing on the Science: JBMR Manuscript Types*  
    Roberto Civitelli, MD, Journal of Bone and Mineral Research

Press Mentions

  • Nickolas to Lead Division of Bone and Mineral Diseases
    Nickolas to Lead Division of Bone and Mineral DiseasesSeptember 26th, 2024
  • Bone Canonical Wnt Signaling Is Downregulated in Type 2 Diabetes and Associates with Higher Advanced Glycation End-Products (AGEs) Content and Reduced Bone Strength
    Bone Canonical Wnt Signaling Is Downregulated in Type 2 Diabetes and Associates with Higher Advanced Glycation End-Products (AGEs) Content and Reduced Bone StrengthApril 15th, 2024

Grant Support

  • Metabolic Skeletal Disorders Training Program GrantNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011–2012
  • Smad4/B-Catenin Signaling Cross-Talk For OsteoblastogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
  • Cadherin Mediated Cell-Cell Interactions In The Bone MicroenvironmentNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011
  • Connexin 43 In Bone FormationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2011
  • Cadherin Regulation Of Osteoblast FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2004
  • Connexin 43 In Bone FormationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2003
  • Cadherin Regulation Of Osteoblast FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–2002
  • Biology Of Cell/Cell Communication In BoneNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2001
  • Intercellular Communication In Bone Cell PhysiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2000
  • Intercellular Communication In Bone Cell PhysiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–1996
  • Intercellular Communication In Bone Cell PhysiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992–1993

Professional Memberships

  • Member
  • American Society for Bone and Mineral Research
    Member
  • American Society for Bone and Mineral Research
    President, 2014

Other Languages

  • Italian